News
Here is our list of the 11 best cancer stocks to buy right now.
2d
TipRanks on MSNBioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer
The intervention being tested is BNT323/DB-1303, an investigational drug administered via intravenous infusion. It is compared against standard chemotherapy options, doxorubicin or paclitaxel, chosen ...
A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...
New data from the Kentucky Cabinet for Health and Family Services shows cases of the virus have jumped significantly in the ...
Released Tuesday, the AAP's recommendations call for routine vaccination of children ages 6 months to 2 years, citing ...
Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, ...
Texas school districts are coming back from summer with a rising number of parents asking for vaccine exemption forms and a ...
For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine ...
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it ...
The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results